NEW YORK (GenomeWeb News) — Thermo Fisher Scientific has opened an RNAi research and services lab in Lafayette, Colo., the company said today.
 
The lab will offer contract RNAi screening and analysis services, including high-throughput screening, along with services and research using the company’s bioreagents, robotics, and other instrument systems, the company said.
 
It will also develop new therapeutic technologies involving RNAi, Thermo said.
 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The Chan Zuckerberg Initiative is investing in Cold Spring Harbor Laboratory's BioRxiv.

A study appearing in PLOS One finds that shortened consent forms don't affect clinical trial participants' understanding of the study.

The National Security Agency monitored signal intelligence for signs of "nefarious" genetic engineering projects, Gizmodo reports.

In Nature this week: barley genome sequenced, method for genotyping and phasing short tandem repeats, and more.